Lipid oxidation products and atherosclerosis

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.38, Iss.4, 2002-04, pp. : 187-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis

By Vindis Cecile Escargueil-Blanc Isabelle Uchida Koji Elbaz Meyer Salvayre Robert Negre-Salvayre Anne

Redox Report, Vol. 12, Iss. 1-2, 2007-02 ,pp. : 96-100

Maney Publishing

Access to resources Recommend Favorite

Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases

Current Medicinal Chemistry, Vol. 25, Iss. 11, 2018-04 ,pp. : 1311-1326

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid pharmacotherapy for treatment of atherosclerosis

By Nicholls Stephen J Pisaniello Anthony D Kataoka Yu Puri Rishi

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 8, 2014-06 ,pp. : 1119-1125

Informa Healthcare

Access to resources Recommend Favorite

Lipid Lowering Agents, Inflammation and Atherosclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 206-216

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products in Regression and Slowing of Progression of Atherosclerosis

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 8, 2010-12 ,pp. : 794-800

Bentham Science Publishers

Access to resources Recommend Favorite